Pharmaceutical Technology's In the Lab eNewsletter
The Lumis electron backscatter diffraction (EBSD) detector incorporates a large-format complementary metal oxide semiconductor (CMOS) sensor to enable higher sample throughput, higher resolution measurements, and precise phase identification.
Thermo Fisher Scientific’s Lumis electron backscatter diffraction (EBSD) detector for electron microscopy is suited to help scientists, researchers, and engineers quickly and accurately identify new materials and understand how the structure of a material affects its properties.
The detector incorporates advanced optics with a new large-format complementary metal oxide semiconductor (CMOS) sensor that collects more than 2.2 megapixels to enable higher sample throughput, higher resolution measurements, and more precise phase identification. The CMOS sensor provides improved sensitivity at high frame rates due to a high dynamic range, increased quantum efficiency, and advanced noise management.
Scientists and researchers in metallurgy, geophysics, and other disciplines can use the Lumis EBSD detector to identify crystallographic phases and grain properties, as well as to monitor structural transformations in samples. The detector is also suited to help microscopists better understand failure mechanisms.
Additional benefits of the Lumis EBSD detector include:
Source: Thermo Fisher Scientific
Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development
March 26th 2024In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.